Page last updated: 2024-09-03

reboxetine and Chronic Insomnia

reboxetine has been researched along with Chronic Insomnia in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	6 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Mendels, J; Schwartz, GE; Stahl, SM	1
Carvalhal, AS; Correa, J; de Abreu, PB; Kapczinski, F; Spode, A	1
Held, K; Kuenzel, HE; Murck, H; Steiger, A; Ziegenbein, M	1
Aguglia, E	1
Benedetti, A; Cassano, G; Mastalli, L; Nardi, A; Perugi, G; Savino, M; Versiani, M	1
Ferguson, JM; Mendels, J; Schwart, GE	1

Reviews

1 review(s) available for reboxetine and Chronic Insomnia

Article	Year
Effects of reboxetine on anxiety, agitation, and insomnia: results of a pooled evaluation of randomized clinical trials. Journal of clinical psychopharmacology, 2002, Volume: 22, Issue:4 Topics: Adult; Antidepressive Agents; Anxiety; Confidence Intervals; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Morpholines; Psychomotor Agitation; Randomized Controlled Trials as Topic; Reboxetine; Sleep Initiation and Maintenance Disorders	2002

Article

Year

Effects of reboxetine on anxiety, agitation, and insomnia: results of a pooled evaluation of randomized clinical trials.

Journal of clinical psychopharmacology, 2002, Volume: 22, Issue:4

Topics: Adult; Antidepressive Agents; Anxiety; Confidence Intervals; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Morpholines; Psychomotor Agitation; Randomized Controlled Trials as Topic; Reboxetine; Sleep Initiation and Maintenance Disorders

2002

Trials

5 trial(s) available for reboxetine and Chronic Insomnia

Article	Year
An open trial of reboxetine in HIV-seropositive outpatients with major depressive disorder. The Journal of clinical psychiatry, 2003, Volume: 64, Issue:4 Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Ambulatory Care; Antidepressive Agents; Comorbidity; Depressive Disorder; Female; HIV Seropositivity; Humans; Hyperhidrosis; Male; Middle Aged; Morpholines; Nausea; Psychiatric Status Rating Scales; Reboxetine; Sleep Initiation and Maintenance Disorders; Treatment Outcome	2003
Reboxetine induces similar sleep-EEG changes like SSRI's in patients with depression. Pharmacopsychiatry, 2004, Volume: 37, Issue:5 Topics: Adrenergic Uptake Inhibitors; Adult; Aged; Depressive Disorder, Major; Electroencephalography; Female; Fluoxetine; Humans; Male; Middle Aged; Morpholines; Reboxetine; Selective Serotonin Reuptake Inhibitors; Sleep Initiation and Maintenance Disorders; Sleep Stages; Wakefulness	2004
Reboxetine in the maintenance therapy of depressive disorder in the elderly: a long-term open study. International journal of geriatric psychiatry, 2000, Volume: 15, Issue:9 Topics: Aged; Antidepressive Agents; Depressive Disorder; Female; Geriatric Psychiatry; Headache; Humans; Male; Morpholines; Nausea; Quality of Life; Reboxetine; Sleep Initiation and Maintenance Disorders; Time Factors; Treatment Outcome	2000
Reboxetine, a selective norepinephrine reuptake inhibitor, is an effective and well-tolerated treatment for panic disorder. The Journal of clinical psychiatry, 2002, Volume: 63, Issue:1 Topics: Adrenergic Uptake Inhibitors; Adult; Agoraphobia; Comorbidity; Constipation; Double-Blind Method; Female; Humans; Male; Morpholines; Norepinephrine; Panic Disorder; Placebos; Psychiatric Status Rating Scales; Reboxetine; Severity of Illness Index; Sleep Initiation and Maintenance Disorders; Treatment Outcome; Xerostomia	2002
Effects of reboxetine on Hamilton Depression Rating Scale factors from randomized, placebo-controlled trials in major depression. International clinical psychopharmacology, 2002, Volume: 17, Issue:2 Topics: Adolescent; Adult; Aged; Antidepressive Agents; Anxiety; Cognition Disorders; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Morpholines; Psychiatric Status Rating Scales; Reboxetine; Sleep Initiation and Maintenance Disorders	2002